New Progress in Pathogenesis and Clinical Treatment of Myasthenia Gravis
Myasthenia gravis is an autoimmune disease that affects neuromuscular junction,and over 80%of myasthenia gravis patients have thymic abnormalities.Main clinical manifestation is muscle weakness symptoms worsening after fatigue.Most patients develop symptoms in the morning or afternoon,being mild in the morning and severe in the evening,and symptoms worsen after physical activity.It can be accompanied by swallowing difficulty,unclear speech,coughing when drinking,and breathing difficulty,which reduces life quality of patients greatly.The paper analysed pathogenesis of myasthenia gravis and explored clinical treatment methods of myasthenia gravis,to understand effect and side effect of different therapies comprehensively and truthfully,and provide basis for treatment of myasthenia gravis based on authentic comprehensive conclusions.
NETL
NSTL
万方数据
